Alveolar capillary dysplasia: Absence of CD117 immunoreactivity of putative hemangioblast precursor cells

Fetal and Pediatric Pathology

Volumn 27, Issue 3, 2008, Pages 127-140

  Chang, Kenneth Tou En ^a,b   Rajadurai, Victor Samuel ^b   Walford, Norman Q ^c   Hwang, Wei Sek ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^c TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

Alveolar capillary dysplasia; CD117; Immunohistochemical staining

Indexed keywords

STEM CELL FACTOR RECEPTOR;

ADOLESCENT; ALVEOLAR CAPILLARY DYSPLASIA; ANGIOGENESIS; ARTICLE; CHILD; CLINICAL ARTICLE; DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS; LUNG CAPILLARY; LUNG DEVELOPMENT; LUNG DISEASE; LUNG INTERSTITIUM; MALE; MESENCHYME CELL; MORPHOGENESIS; PERSISTENT PULMONARY HYPERTENSION; PRIORITY JOURNAL; STEM CELL;

ADULT; CAPILLARIES; CASE-CONTROL STUDIES; EMBRYONIC STEM CELLS; FATAL OUTCOME; FEMALE; GESTATIONAL AGE; HEMATOPOIESIS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; MALE; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PROTO-ONCOGENE PROTEINS C-KIT; PULMONARY ALVEOLI; PULMONARY ARTERY; RETROSPECTIVE STUDIES;

EID: 47549084077     PISSN: 15513815     EISSN: 15513823     Source Type: Journal    
DOI: 10.1080/15513810802077594     Document Type: Article

References (47)

1. Cater G, Thibeault DW, Beatty EC, Jr., Kilbride HW, Huntrakoon M. Misalignment of lung vessels and alveolar capillary dysplasia: a cause of persistent pulmonary hypertension. J Pediatr 114:293-300, 1989.
2. Wagenvoort CA. Misalignment of lung vessels: a syndrome causing persistent neonatal pulmonary hypertension. Hum Pathol 17:727-30, 1986.
3. Alameh J, Bachiri A, Devisme L, et al. Alveolar capillary dysplasia: a cause of persistent pulmonary hypertension of the newborn. Eur J Pediatr 161:262-266, 2002.
4. Haraida S, Lochbuhler H, Heger A, et al. Congenital alveolar capillary dysplasia: rare cause of persistent pulmonary hypertension. Pediatr Pathol Lab Med 17:959-975, 1997.
5. Cullinane C, Cox PN, Silver MM. Persistent pulmonary hypertension of the newborn due to alveolar capillary dysplasia. Pediatr Pathol 12:499-514, 1992.
6. Kane TD, Greenberg JM, Bove KE, Warner BW. Alveolar capillary dysplasia with misalignment of the pulmonary veins: a rare but fatal cause of neonatal respiratory failure. Pediatr Surg Int 14:89-91, 1998.
7. Eulmesekian P, Cutz E, Parvez B, Bohn D, Adatia I. Alveolar capillary dysplasia: a six-year single center experience. J Perinat Med 33:347-352, 2005.
8. Steinhorn RH, Cox PN, Fineman JR, et al. Inhaled nitric oxide enhances oxygenation but not survival in infants with alveolar capillary dysplasia. J Pediatr 130:417-422, 1997.
9. Bond SJ, Lee DJ, Stewart DL, Buchino JJ. Open lung biopsy in pediatric patients on extracorporeal membrane oxygenation. J Pediatr Surg 31:1376-1378, 1996.
10. Inwald D, Brown K, Gensini F, Malone M, Goldman A. Open lung biopsy in neonatal and paediatric patients referred for extracorporeal membrane oxygenation (ECMO). Thorax 59:328-333, 2004.
11. Pucci A, Zanini C, Ferrero F, et al. Misalignment of lung vessels: diagnostic role of conventional histology and immunohistochemistry. Virchows Arch 442:597-600, 2003.
12. Sirkin W, O'Hare BP, Cox PN, Perrin D, Cutz E, Silver MM. Alveolar capillary dysplasia: lung biopsy diagnosis, nitric oxide responsiveness, and bronchial generation count. Pediatr Pathol Lab Med 17:125-132, 1997.
13. Kelly LK, Porta NF, Goodman DM, Carroll CL, Steinhorn RH. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. J Pediatr 141:830-832, 2002.
14. Kinugasa H, Horigome H, Sugiura M, Saito T, Iijima T, Matsui A. Intravenous prostacyclin combined with inhaled nitric oxide therapy for an infant with alveolar capillary dysplasia. Pediatr Int 44:525-527, 2002.
15. Parker TA, Ivy DD, Kinsella JP, et al. Combined therapy with inhaled nitric oxide and intravenous prostacyclin in an infant with alveolar-capillary dysplasia. Am J Respir Crit Care Med 155:743-746, 1997.
16. Chelliah BP, Brown D, Cohen M, Talleyrand AJ, Shen-Schwarz S. Alveolar capillary dysplasia - a cause of persistent pulmonary hypertension unresponsive to a second course of extracorporeal membrane oxygenation. Pediatrics 96:1159-1161, 1995.
17. Michalsky MP, Arca MJ, Groenman F, Hammond S, Tibboel D, Caniano DA. Alveolar capillary dysplasia: a logical approach to a fatal disease. J Pediatr Surg 40:1100-1105, 2005.
18. Boggs S, Harris MC, Hoffman DJ, et al. Misalignment of pulmonary veins with alveolar capillary dysplasia: affected siblings and variable phenotypic expression. J Pediatr 124:125-128, 1994.
19. Sen P, Thakur N, Stockton DW, Langston C, Bejjani BA. Expanding the phenotype of alveolar capillary dysplasia (ACD). J Pediatr 145:646-651, 2004.
20. Vassal HB, Malone M, Petros AJ, Winter RM. Familial persistent pulmonary hypertension of the newborn resulting from misalignment of the pulmonary vessels (congenital alveolar capillary dysplasia). J Med Genet 35:58-60, 1998.
21. Garola RE, Thibeault DW. Alveolar capillary dysplasia, with and without misalignment of pulmonary veins: an association of congenital anomalies. Am J Perinatol 15:103-107, 1998.
22. Lane JR, Siwik E, Preminger T, Stork E, Spector M. Prospective diagnosis of alveolar capillary dysplasia in infants with congenital heart disease. Am J Cardiol 84:618-620, A9-10, 1999.
23. Rabah R, Poulik JM. Congenital alveolar capillary dysplasia with misalignment of pulmonary veins associated with hypoplastic left heart syndrome. Pediatr Dev Pathol 4:167-174, 2001.
24. Roth W, Bucsenez D, Blaker H, Berger I, Schnabel PA. Misalignment of pulmonary vessels with alveolar capillary dysplasia: association with atrioventricular septal defect and quadricuspid pulmonary valve. Virchows Arch 448:375-378, 2006.
25. Taborosi B, Todt-Pingel I, Kayser G, Dittrich S. A rare case of aortic coarctation and ventricular septal defect combined with alveolar capillary dysplasia. Pediatr Cardiol 28:319-323, 2007.
26. Antao B, Samuel M, Kiely E, Spitz L, Malone M. Congenital alveolar capillary dysplasia and associated gastrointestinal anomalies. Fetal Pediatr Pathol 25:137-145, 2006.
27. Gutierrez C, Rodriguez A, Palenzuela S, Forteza C, Rossello JL. Congenital misalignment of pulmonary veins with alveolar capillary dysplasia causing persistent neonatal pulmonary hypertension: report of two affected siblings. Pediatr Dev Pathol 3:271-276, 2000.
28. Usui N, Kamiyama M, Kamata S, Yoneda A, Tazuke Y, Fukuzawa M. A novel association of alveolar capillary dysplasia and duodenal atresia with paradoxical dilatation of the duodenum. J Pediatr Surg 39:1808-1811, 2004.
29. Vick RN, Owens T, Moise KJ, Chescheir N, Bukowski TP. Urethral atresia in a neonate with alveolar capillary dysplasia and pulmonary venous misalignment. Urology 55:774, 2000.
30. Merchak A, Lueder GT, White FV, Cole FS. Alveolar capillary dysplasia with misalignment of pulmonary veins and anterior segment dysgenesis of the eye: a report of a new association and review of the literature. J Perinatol 21:327-330, 2001.
31. Schirmer-Zimmerman H, Hammersen G, Scheuerlen W, Griese M, Brasch F, Rauch A. CR3/108 - mongenital alveolar capillary dysplasia with familiary microphthalmia. Paediatr Respir Rev 7 Suppl 1:S326, 2006.
32. Langston C. Misalignment of pulmonary veins and alveolar capillary dysplasia. Pediatr Pathol 11:163-170, 1991.
33. Miettinen M, Lasota J. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol 13:205-220, 2005.
34. deMello DE. Pulmonary pathology. Semi Neonatol 9:311-329, 2004.
35. Hislop AA. Airway and blood vessel interaction during lung development. J Anat 201:325-334, 2002.
36. Reid LM. Structural development of the lung and pulmonary circulation. In Respiratory Distress Syndrome. Raivio K HN, Kouvalainen K, Valimaki I, ed. London: Academic Press, pp. 3-18, 1984.
37. Schachtner SK, Wang Y, Scott Baldwin H. Qualitative and quantitative analysis of embryonic pulmonary vessel formation. Am J Respir Cell Mol Biol 22:157-165, 2000.
38. Hislop A RL. Formation of the pulmonary vasculature. In Development of the Lung. Hodson WA, ed. New York: Marcel Dekker, pp. 37-86, 1977.
39. Stenmark KR, Gebb SA. Lung vascular development: breathing new life into an old problem. Am J Respir Cell Mol Biol 28:133-137, 2003.
40. Noden DM. Embryonic origins and assembly of blood vessels. Am Rev Respir Dis 140:1097-1103, 1989.
41. deMello DE, Reid LM. Embryonic and early fetal development of human lung vasculature and its functional implications. Pediatr Dev Pathol 3:439-449, 2000.
42. deMello DE, Sawyer D, Galvin N, Reid LM. Early fetal development of lung vasculature. Am J Respir Cell Mol Biol 16:568-581, 1997.
43. Galambos C, Ng YS, Ali A, et al. Defective pulmonary development in the absence of heparin-binding vascular endothelial growth factor isoforms. Am J Respir Cell Mol Biol 27:194-203, 2002.
44. Han RN, Babaei S, Robb M, et al. Defective lung vascular development and fatal respiratory distress in endothelial NO synthase-deficient mice: a model of alveolar capillary dysplasia? Circ Res 94:1115-1123, 2004.
45. Fukumura D, Gohongi T, Kadambi A, et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 98:2604-2609, 2001.
46. Schatteman GC, Dunnwald M, Jiao C. Biology of bone marrow-derived endothelial cell precursors. Am J Physiol Heart Circ Physiol 292:H1-18, 2007.
47. Li TS, Hamano K, Nishida M, et al. CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation. Am J Physiol Heart Circ Physiol 285:H931-937, 2003.